Clinical Trial Update: Study of FemVue(TM) Sono Tubal Evaluation System Method Comparison to HSG [NA]

View source ↗

Summary

The clinical trial evaluating the FemVue Sono Tubal Evaluation System for tubal patency, compared to hysterosalpingography (HSG), has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Femasys Inc. | Conditions: Fallopian Tube Patency Tests | NA | Status: WITHDRAWN